Digital Health Round-Up: DTA 2023 Highlights; Pear Assets; Medtronic’s Spin-Off; New Business

In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb and Hannah Daniel discuss highlights from their DTA Summit coverage in Washington. Reed Miller talked to Frank Chan, the president of Medtronic’s Patient Monitoring, about plans for the patient monitoring as an independent company and Bayer AG’s new business unit focusing on digital health. Listen to the podcast via the player below: Medtech Insight articles addressing topics discussed in this episode: Digital Therapeutics Alliance Summit DTA Panel Discusses Future Of Digital Therapeutics, Obstacles To Wider Adoption The Afterlife Of Pear Therapeutics: Korean DTx Maker Discusses Vision For Salvaged Migraine Assets The Frontier Of Digital Therapeutics Regulations Pear Bankruptcy Filing Highlights Difficult Challenges Facing Digital Therapeutics Exec Chat: Medtronic’s Chan Discusses Future Of Connected Care In A Stressed System Minute Insight: Bayer Launches Precision Health Unit To Focus On Digital Consumer Health